| Literature DB >> 28089139 |
Abstract
Once a widely ignored phytocannabinoid, cannabidiol now attracts great therapeutic interest, especially in epilepsy and cancer. As with many rising trends, various myths and misconceptions have accompanied this heightened public interest and intrigue. This forum article examines and attempts to clarify some areas of contention.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28089139 DOI: 10.1016/j.tips.2016.12.004
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN: 0165-6147 Impact factor: 14.819